{"text": ["Why", "You", "Should", "Buy", "ABBV", "Stock", "for", "Income", "and", "Value"], "created_at": "2019-03-19 19:06:27"}
{"text": ["Why", "You", "Should", "Buy", "ABBV", "Stock", "for", "Income", "and", "Value"], "created_at": "2019-03-19 19:06:27"}
{"text": ["Why", "You", "Should", "Buy", "ABBV", "Stock", "for", "Income", "and", "Value"], "created_at": "2019-03-19 14:21:36"}
{"text": ["FDA", "puts", "partial", "hold", "on", "clinical", "trials", "of", "AbbVie's", "cancer", "drug"], "created_at": "2019-03-19 13:36:29"}
{"text": ["AbbVie", "stock", "down", "0.8%", "after", "FDA", "places", "hold", "on", "clinical", "trials", "of", "venetoclax", "as", "a", "treatment", "for", "multiple", "myeloma"], "created_at": "2019-03-19 13:07:00"}
{"text": ["AbbVie", "Provides", "Update", "on", "VENCLEXTA\u00ae/VENCLYXTO\u00ae", "(venetoclax)", "Multiple", "Myeloma", "Program"], "created_at": "2019-03-19 12:45:00"}
{"text": ["AbbVie", "(ABBV)", "Stock", "Sinks", "As", "Market", "Gains:", "What", "You", "Should", "Know"], "created_at": "2019-03-19 00:10:15"}
{"text": ["AbbVie", "(ABBV)", "Stock", "Sinks", "As", "Market", "Gains:", "What", "You", "Should", "Know"], "created_at": "2019-03-19 00:10:15"}
